We are live on
!
Find out more
IE
Israel Englander Millennium Management
AUM
$276B
1-Year Est. Return
44.8%
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
This Fund
S&P 500
This Quarter
Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
(+2.3%)
Cap. Flow
-$692M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Littelfuse
LFUS
$10.3B
| $5.22M | ﹤0.01% |
19,107
-6,882
| -26% | -$1.83M |
|
|
SHAC
2777
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $5.22M | ﹤0.01% |
536,338
+480,850
| +867% | +$4.65M |
|
2778
The Ensign Group
ENSG
$10.1B
| $5.21M | ﹤0.01% |
69,628
+14,969
| +27% | +$1.24M |
|
2779
Malibu Boats
MBUU
$538M
| $5.19M | ﹤0.01% |
74,218
+27,190
| +58% | +$2.04M |
|
2780
Columbia Financial
CLBK
$1.2B
| $5.19M | ﹤0.01% |
280,722
-109,260
| -28% | -$1.95M |
|
2781
CALL
Welltower
WELL
$172B
| $5.19M | ﹤0.01% |
+63,000
| New | +$5.41M |
|
|
BLUE
2782
DELISTED
bluebird bio
BLUE
| $5.18M | ﹤0.01% |
20,945
-11,121
| -35% | -$3.18M |
|
2783
Donaldson
DCI
$10.7B
| $5.18M | ﹤0.01% |
90,303
+43,390
| +92% | +$2.8M |
|
|
SSAAU
2784
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
| $5.18M | ﹤0.01% |
520,736
-229,022
| -31% | -$2.28M |
|
2785
Adecoagro
AGRO
$1.55B
| $5.18M | ﹤0.01% |
573,551
-366,330
| -39% | -$3.44M |
|
2786
Fulton Financial
FULT
$4.52B
| $5.17M | ﹤0.01% |
338,183
+100,400
| +42% | +$1.55M |
|
|
FCAX.U
2787
DELISTED
Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant
FCAX.U
| $5.17M | ﹤0.01% |
527,110
+5,107
| +1% | +$50.8K |
|
2788
MaxCyte
MXCT
$126M
| $5.16M | ﹤0.01% |
+422,442
| New | +$6.37M |
|
2789
Revolution Medicines
RVMD
$44.6B
| $5.14M | ﹤0.01% |
186,971
+145,151
| +347% | +$4.22M |
|
|
KIIIU
2790
DELISTED
Kismet Acquisition Three Corp. Unit
KIIIU
| $5.14M | ﹤0.01% |
518,895
-90,345
| -15% | -$894K |
|
|
RMGC
2791
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
| $5.13M | ﹤0.01% |
527,162
-670,963
| -56% | -$6.52M |
|
2792
Seacoast Banking Corp of Florida
SBCF
$3.33B
| $5.12M | ﹤0.01% |
151,444
+14,525
| +11% | +$460K |
|
2793
Archrock
AROC
$5.48B
| $5.11M | ﹤0.01% |
619,739
-25,298
| -4% | -$203K |
|
2794
PUT
Plug Power
PLUG
$3.06B
| $5.11M | ﹤0.01% |
200,000
+50,000
| +33% | +$1.34M |
|
2795
Signet Jewelers
SIG
$3.21B
| $5.1M | ﹤0.01% |
64,611
-61,590
| -49% | -$4.52M |
|
2796
Amerant Bancorp
AMTB
$1.13B
| $5.1M | ﹤0.01% |
206,153
-23,293
| -10% | -$550K |
|
|
CIXX
2797
DELISTED
CI Financial Corp.
CIXX
| $5.1M | ﹤0.01% |
250,728
+150,015
| +149% | +$2.88M |
|
|
PRDS
2798
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $5.09M | ﹤0.01% |
511,883
-10,620
| -2% | -$106K |
|
2799
CALL
DuPont de Nemours
DD
$18.5B
| $5.09M | ﹤0.01% |
59,591
+56,086
| +1,600% | +$5.2M |
|
|
OMIC
2800
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $5.08M | ﹤0.01% |
15,140
+8,093
| +115% | +$4.15M |
|
Similar funds
JT
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.